Stockscreener 앱 받기
18.12
4.33%
-0.82
시장 영업 전:
17.83
-0.29
-1.60%
전일 마감가:
$18.94
열려 있는:
$18.99
하루 거래량:
6.68M
Relative Volume:
1.82
시가총액:
$13.46B
수익:
$956.00K
순이익/손실:
$-221.32M
주가수익비율:
-56.62
EPS:
-0.32
순현금흐름:
$-142.25M
1주 성능:
-3.75%
1개월 성능:
-32.11%
6개월 성능:
-12.84%
1년 성능:
-38.53%
1일 변동 폭
$18.00
$19.10
1주일 범위
$16.31
$19.97
52주 변동 폭
$15.55
$36.91
Summit Therapeutics Inc Stock (SMMT) Company Profile
명칭
Summit Therapeutics Inc
전화
305-203-2034
주소
601 BRICKELL KEY DRIVE, MIAMI
SMMT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SMMT
Summit Therapeutics Inc
|
18.12 | 14.07B | 956.00K | -221.32M | -142.25M | -0.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.36 | 100.82B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.24 | 60.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
575.06 | 60.69B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
752.32 | 46.32B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
327.20 | 36.58B | 3.81B | -644.79M | -669.77M | -6.24 |
Summit Therapeutics Inc Stock (SMMT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-04 | 개시 | Guggenheim | Buy |
| 2025-08-19 | 개시 | Piper Sandler | Neutral |
| 2025-07-01 | 개시 | UBS | Buy |
| 2025-06-11 | 개시 | Leerink Partners | Underperform |
| 2025-03-26 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-03-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-03-12 | 개시 | Evercore ISI | Outperform |
| 2025-02-28 | 개시 | Goldman | Buy |
| 2025-01-08 | 개시 | Truist | Buy |
| 2024-12-11 | 개시 | Wells Fargo | Overweight |
| 2024-12-06 | 개시 | Jefferies | Buy |
| 2024-11-04 | 개시 | JMP Securities | Mkt Outperform |
| 2024-09-27 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-08-12 | 개시 | H.C. Wainwright | Buy |
| 2024-05-07 | 개시 | Citigroup | Buy |
| 2024-03-26 | 개시 | Stifel | Buy |
| 2018-06-28 | 다운그레이드 | Janney | Buy → Neutral |
| 2018-05-02 | 개시 | Janney | Buy |
| 2018-04-12 | 재확인 | Needham | Buy |
| 2018-02-13 | 개시 | BTIG Research | Buy |
| 2018-01-04 | 개시 | SunTrust | Buy |
| 2017-12-01 | 재개 | H.C. Wainwright | Buy |
| 2016-11-16 | 재확인 | RBC Capital Mkts | Outperform |
| 2016-10-05 | 재확인 | Needham | Buy |
| 2016-09-16 | 개시 | H.C. Wainwright | Buy |
| 2015-03-30 | 개시 | Needham | Buy |
| 2015-03-30 | 개시 | Oppenheimer | Outperform |
모두보기
Summit Therapeutics Inc 주식(SMMT)의 최신 뉴스
Barclays Initiates Summit Therapeutics at Underweight With $13 Price Target - MarketScreener
Summit Therapeutics Inc. Investigated by the Portnoy Law Firm - GlobeNewswire
Focus Partners Wealth Boosts Stake in Summit Therapeutics PLC $SMMT - MarketBeat
695,000 Shares in Summit Therapeutics PLC $SMMT Acquired by Siren L.L.C. - MarketBeat
Summit Therapeutics (NASDAQ:SMMT) CEO Robert W. Duggan Acquires 333,394 Shares - MarketBeat
Summit Therapeutics (NASDAQ:SMMT) CEO Mahkam Zanganeh Purchases 333,394 Shares - MarketBeat
Fed Meeting: What is Summit Therapeutics Inc. s revenue forecastJuly 2025 Action & Accurate Buy Signal Alerts - خودرو بانک
SMMT: HC Wainwright & Co. Reiterates Buy Rating at $50.00 | SMMT Stock News - GuruFocus
Is now a turning point for Summit Therapeutics Inc.July 2025 Short Interest & Capital Efficiency Focused Strategies - newser.com
Is a relief rally coming for Summit Therapeutics Inc. holdersMarket Performance Summary & AI Enhanced Trade Execution Alerts - newser.com
Sectors Review: What’s next for Summit Therapeutics Inc. stockAnalyst Downgrade & Stepwise Trade Signal Guides - خودرو بانک
Sectors Review: Can Summit Therapeutics Inc beat the S P 500Dollar Strength & Advanced Swing Trade Entry Alerts - خودرو بانک
Real time alert setup for Summit Therapeutics Inc. performanceWeekly Risk Summary & Precise Buy Zone Tips - newser.com
Shorts Report: Can Summit Therapeutics Inc stock outperform in a bear marketInsider Buying & Expert Approved Momentum Ideas - خودرو بانک
Trend Recap: Can Summit Therapeutics Inc be the next market leaderMarket Risk Report & High Accuracy Trade Alerts - خودرو بانک
Update Recap: What are Summit Therapeutics Inc.’s recent SEC filings showingIPO Watch & Stepwise Trade Execution Plans - خودرو بانک
Bronstein, Gewirtz & Grossman, LLC Encourages Summit Therapeutics Inc. (SMMT) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
How to use Fibonacci retracement on Summit Therapeutics Inc.July 2025 Earnings & Fast Moving Stock Watchlists - newser.com
Using Bollinger Bands to evaluate Summit Therapeutics Inc.July 2025 Summary & Scalable Portfolio Growth Methods - newser.com
Short interest data insights for Summit Therapeutics Inc.Portfolio Risk Report & AI Driven Price Predictions - newser.com
Jim Cramer: Ring The Register On This Real Estate 'Meme' Stock - Benzinga
Will Summit Therapeutics Inc. benefit from macro trendsWeekly Trading Summary & Community Verified Trade Signals - newser.com
Summit Therapeutics (NASDAQ:SMMT) Shares Down 6.2%Should You Sell? - MarketBeat
How institutional ownership impacts Summit Therapeutics Inc. stockPortfolio Profit Report & High Yield Equity Trading Tips - newser.com
Tick level data insight on Summit Therapeutics Inc. volatilityRecession Risk & Weekly High Potential Stock Alerts - newser.com
Will Summit Therapeutics Inc. bounce back from current supportWeekly Trend Report & Fast Gain Stock Tips - newser.com
Is Summit Therapeutics Inc. reversing from oversold territory2025 Big Picture & High Conviction Buy Zone Picks - newser.com
Summit Therapeutics (NASDAQ:SMMT) Shares Gap Up on Insider Buying Activity - MarketBeat
Summit Therapeutics Inc. stock chart pattern explainedRate Hike & AI Powered Buy and Sell Recommendations - newser.com
Summit Therapeutics (NASDAQ:SMMT) Shares Gap DownTime to Sell? - MarketBeat
Summit Therapeutics PLC (NASDAQ:SMMT) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Summit Therapeutics' (SMMT) Buy Rating Reiterated at HC Wainwright - MarketBeat
Summit Therapeutics' (SMMT) "Overweight" Rating Reaffirmed at Cantor Fitzgerald - MarketBeat
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc.SMMT - PR Newswire
Adage Capital Partners GP L.L.C. Takes Position in Summit Therapeutics PLC $SMMT - MarketBeat
Summit Therapeutics (SMMT) Shares Surge After CEO Stock Purchases - GuruFocus
Summit Therapeutics Stock (SMMT) Opinions on HARMONi Trial Data Release - Quiver Quantitative
Summit Therapeutics stock gains on insider buys (SMMT:NASDAQ) - Seeking Alpha
Leerink Partners Sticks to Its Sell Rating for Summit Therapeutics (SMMT) - The Globe and Mail
Duggan buys Summit Therapeutics (SMMT) shares worth $5.9m By Investing.com - Investing.com Nigeria
Summit Therapeutics director Zanganeh buys shares worth $5.9m By Investing.com - Investing.com Nigeria
Duggan buys Summit Therapeutics (SMMT) shares worth $5.9m - Investing.com
Summit Therapeutics director Zanganeh buys shares worth $5.9m - Investing.com
Summit Therapeutics(SMMT.US) 10% Shareholder Buys US$5.98 Million in Common Stock - 富途牛牛
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Summit Therapeutics Inc. (SMMT) And Encourages Stockholders to Reach Out - ACCESS Newswire
Guggenheim Initiates Summit Therapeutics (SMMT) With a Buy Rating - MSN
Polar Asset Management Partners Inc. Has $240,000 Holdings in Summit Therapeutics PLC $SMMT - MarketBeat
Vident Advisory LLC Makes New Investment in Summit Therapeutics PLC $SMMT - MarketBeat
CORRECTION -- Summit Therapeutics Inc. Investigated by the Portnoy Law Firm - GlobeNewswire
Summit’s Stock Plunge: What Lies Ahead? - StocksToTrade
Bronstein, Gewirtz & Grossman, LLC Is Investigating Summit Therapeutics Inc. (SMMT) And Encourages Stockholders to Connect - Louisiana First News
Summit Therapeutics Inc (SMMT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.77%
1.53%
자본화:
|
볼륨(24시간):